Home / Companies / Telix Pharmaceuticals Limited / 21 May 2025
Telix Pharmaceuticals Limited: meeting of 21 May 2025
Votes reported on Form N-PX, item by item
43 Form N-PX filers reported votes at the Telix Pharmaceuticals Limited meeting of 21 May 2025. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 96.5% of reported votes for; 5 filers withheld from or voted against at least one nominee.
171 vote records from 34 filers. 0 of the 34 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
39 vote records from 13 filers. 0 of the 2 filers that marked the item either way voted against management. 11 filers reported this item without a management mark.
SHAREHOLDER RIGHTS AND DEFENSESIssuer
SHAREHOLDER RIGHTS AND DEFENSES: management items
Management items in this category are shown together; filers word and number them differently.
55 vote records from 33 filers. 0 of the 33 filers that marked the item either way voted against management.
EXTRAORDINARY TRANSACTIONSIssuer
EXTRAORDINARY TRANSACTIONS: management items
Management items in this category are shown together; filers word and number them differently.
108 vote records from 32 filers. 0 of the 32 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
75 vote records from 34 filers. 0 of the 34 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
259 vote records from 34 filers. 2 of the 31 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
15 vote records from 3 filers. No filer marked a management recommendation, so no against-management figure is reported. 3 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay |
|---|---|---|
| Vanguard | For | No report |
| BlackRock and iShares | For | For |
| Fidelity | For | No report |
| Dimensional | For | No report |
| State Street and SPDR | For | No report |
| American Century | For | No report |
| Franklin Templeton | For | No report |
| Equitable | For | No report |
| Charles Schwab | For | No report |
| Nuveen and TIAA | For | No report |
| J.P. Morgan | No report | For |
| Jackson National funds | For | For |
| Northern Trust and FlexShares | For | For |
| Lincoln Financial | For | No report |
| First Trust | For | No report |
| Victory Capital | For | No report |
| AllianceBernstein | For | No report |
| American Beacon | For | No report |
| Lord Abbett | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Telix Pharmaceuticals Limited meeting?
43 Form N-PX filers reported votes at the meeting of 21 May 2025. On say-on-pay, 0 of 2 voted against management (0.0%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Telix Pharmaceuticals Limited on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Telix Pharmaceuticals Limited
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Telix Pharmaceuticals Limited with a meeting date within three days of 21 May 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.